{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:47:08Z","timestamp":1790182028311,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1136\/ard.2005.044420","type":"journal-article","created":{"date-parts":[[2005,11,4]],"date-time":"2005-11-04T01:19:37Z","timestamp":1131067177000},"page":"853-858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":173,"title":["Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations"],"prefix":"10.1016","volume":"65","author":[{"given":"P M","family":"Aries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Voswinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Both","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"N\u00f6lle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Holl-Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Lamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W L","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2005.044420_bib1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/rheumatology\/41.11.1303","article-title":"Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener\u00e2\u20ac\u2122s granulomatosis","volume":"41","author":"Lamprecht","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2005.044420_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.1995.tb02268.x","article-title":"Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin","volume":"101","author":"Richter","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2005.044420_bib3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.ASN.0000048716.42876.14","article-title":"15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy","volume":"14","author":"Birck","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/ard.2005.044420_bib4","first-page":"351","article-title":"Compassionate treatment of Wegener\u00e2\u20ac\u2122s granulomatosis with rabbit anti-thymocyte globin","volume":"43","author":"Hagen","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1136\/ard.2005.044420_bib5","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.10947","article-title":"Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy","volume":"48","author":"Silverman","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2005.044420_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","article-title":"Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"Keogh","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2005.044420_bib7","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W","article-title":"Response of Wegener\u00e2\u20ac\u2122s granulomatosis to anti-CD20 chimeric monoclonal antibody therapy","volume":"44","author":"Specks","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2005.044420_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.20717","article-title":"Rituximab and Wegener\u00e2\u20ac\u2122s granulomatosis: are B cells a target in vasculitis treatment?","volume":"52","author":"Sneller","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2005.044420_bib9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener\u00e2\u20ac\u2122s granulomatosis","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2005.044420_bib10","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"QJM"},{"key":"10.1136\/ard.2005.044420_bib11","first-page":"31","article-title":"Development and validation of a disease extent index for ANCA-associated vasculitides","volume":"55","author":"De Groot","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1136\/ard.2005.044420_bib12","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/rheumatology\/41.11.1313","article-title":"A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener\u00e2\u20ac\u2122s granulomatosis and microscopic polyangiitis","volume":"41","author":"Csernok","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2005.044420_bib13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/rheumatology\/keh300","article-title":"High-dose intravenous azathioprine pulse treatment in refractory Wegener\u00e2\u20ac\u2122s granulomatosis","volume":"43","author":"Aries","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2005.044420_bib14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I","article-title":"Cytokine profiles in Wegener\u00e2\u20ac\u2122s granulomatosis: predominance of type 1 (Th1) in granulomatous inflammation","volume":"42","author":"Csernok","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2005.044420_bib15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/thorax.56.10.751","article-title":"CD28 negative T cells are enriched in granulomas lesions of the respiratory tract in Wegener\u00e2\u20ac\u2122s granulomatosis","volume":"56","author":"Lamprecht","year":"2001","journal-title":"Thorax"},{"key":"10.1136\/ard.2005.044420_bib16","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0002-9440(10)61118-2","article-title":"Peripheral blood and granuloma CD4+CD28- T cells are the major source of interferon-\u00ce\u00b3 and tumor necrosis factor-\u00ce\u00b1 in Wegeners granulomatosis","volume":"160","author":"Komocsi","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.2005.044420_bib17","first-page":"24","article-title":"B lymphocytes infiltrating Wegener\u00e2\u20ac\u2122s granuloma: the immunoglobulin VH gene repertoire from granulomatous tissues displays an antigen-driven maturation and suggests a microbial trigger","volume":"6","author":"Voswinkel","year":"2004","journal-title":"Arthritis Res"},{"key":"10.1136\/ard.2005.044420_bib18","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2004-01-0267","article-title":"Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo","volume":"104","author":"Pfister","year":"2004","journal-title":"Blood"},{"key":"10.1136\/ard.2005.044420_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/bjo.2004.050039","article-title":"Orbital socket contracture: a complication of inflammatory orbital disease in patients with Wegener\u00e2\u20ac\u2122s granulomatosis","volume":"89","author":"Talar-Williams","year":"2005","journal-title":"Br J Opthalmol"},{"key":"10.1136\/ard.2005.044420_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1034\/j.1600-065X.2003.00055.x","article-title":"The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease","volume":"194","author":"O\u00e2\u20ac\u2122Connor","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1136\/ard.2005.044420_bib21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/1521-4141(200204)32:4<923::AID-IMMU923>3.0.CO;2-1","article-title":"Plasma cells for a lifetime ?","volume":"32","author":"Manz","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard.2005.044420_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/40540","article-title":"A lifetime of plasma cells in the bone marrow","volume":"388","author":"Manz","year":"1997","journal-title":"Nature"},{"key":"10.1136\/ard.2005.044420_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1074-7613(00)80541-5","article-title":"Humoral immunity due to long-lived plasma cells","volume":"8","author":"Slifka","year":"1998","journal-title":"Immunity"},{"key":"10.1136\/ard.2005.044420_bib24","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1084\/jem.20040168","article-title":"Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB\/W mice","volume":"199","author":"Hoyer","year":"2004","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2005.044420_bib25","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1078\/0171-2985-00204","article-title":"The role of long-lived plasma-cells in autoimmunity","volume":"206","author":"Arce","year":"2002","journal-title":"Immunobiology"},{"key":"10.1136\/ard.2005.044420_bib26","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/art.11181","article-title":"Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis","volume":"48","author":"Cambridge","year":"2003","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724201114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724201114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2005.044420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T14:29:19Z","timestamp":1736087359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724201114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0003496724201114"],"URL":"https:\/\/doi.org\/10.1136\/ard.2005.044420","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2005.044420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Copyright 2006 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}